Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]

Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]

Bibliographic Details
Main Authors:	Mengjiao Wu, Yan Wang, Di Yang, Ying Gong, Feng Rao, Rui Liu, Danna Yeerken, Jinting Li, Jiawen Fan, Jie Chen, Weimin Zhang, Qimin Zhan
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396420304175

Similar Items

A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinomaResearch in context
by: Mengjiao Wu, et al.
Published: (2019-03-01)

EBioMedicine: Bridging Two Cultures to Improve Health
Published: (2014-11-01)

Corrigendum to ‘Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis’ [EBioMedicine 41 (2019) 538–555]
by: Xiaojuan He, et al.
Published: (2020-02-01)

Corrigendum to “Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011–2016” EBioMedicine 41 (2019) 488–496
by: Nadav Topaz, et al.
Published: (2020-01-01)

Corrigendum to “Syk and ye shall find” [EBioMedicine 2 (11) (2015) 190-1591]
by: Benjamin Wolozin, et al.
Published: (2016-06-01)

Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604]
by: Zhaolai Qi, et al.
Published: (2020-10-01)

Corrigendum to ‘‘Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model’’ [EBioMedicine 41 (2019) 465–478]
by: Usha K. Nivarthi, et al.
Published: (2020-04-01)

Corrigendum to “Intergenerational Transmission of Enhanced Seizure Susceptibility after Febrile Seizures” (EBioMedicine 17 (2017) 206–215)
by: Dengchang Wu, et al.
Published: (2017-12-01)

Corrigendum to “Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases” [EBioMedicine 54 (2020) 102730]
by: Jing Tan, et al.
Published: (2020-11-01)

Corrigendum to “Linezolid for Treating Tuberculosis: A Delicate Balancing Act” [EBioMedicine 2 (11) (November 2015) 1568–1569]
Published: (2016-01-01)

Erratum to “Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis” [EBioMedicine 2 (8), August 2015, 868–873]
by: Mamoudou Maiga, et al.
Published: (2015-11-01)

Corrigendum to ‘Combined gene essentiality scoring improves the prediction of cancer dependency maps’ [EBioMedicine 50 (2019) 66–79]
by: Wenyu Wang, et al.
Published: (2020-01-01)

Corrigendum to “Serotonin Activates Bacterial Quorum Sensing and Enhances the Virulence of Pseudomonas aeruginosa in the Host” [EBioMedicine 9 (2016) 161–169]
by: Leslie D. Knecht, et al.
Published: (2017-09-01)

Corrigendum to “Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease” [EBioMedicine 37 (2018) 269–280]
by: Shaoqun Shu, et al.
Published: (2021-01-01)

Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
by: Zhiwei Sun, et al.
Published: (2021-08-01)

Corrigendum to ‘Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apcmin/+ mice’ [EBioMedicine 48 (2019) 301–315]
by: Lu Li, et al.
Published: (2020-03-01)

Corrigendum to: “Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers” [EBioMedicine 8 (2016) 117–131]
by: Anuradha Illendula, et al.
Published: (2017-11-01)

Retraction notice to ‘The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC’ [EBioMedicine 37 (2018) 188–204]
by: Dan Jin, et al.
Published: (2021-01-01)

Corrigendum to ‘Silencing of circular RNA HIPK2 in neural stem cells enhances functional recovery following ischaemic stroke’ [EBioMedicine 52 (2020) 102660]
by: Guangtian Wang, et al.
Published: (2020-05-01)

Erratum to “Mechanistic Studies of the Negative Epistatic Malaria-protective Interaction Between Sickle Cell Trait and α+thalassemia” [EBioMedicine 1 (2014) 29–36]
by: D. Herbert Opi, et al.
Published: (2015-08-01)

Corrigendum to “Increased BOLD Signals Elicited by High Gamma Auditory Stimulation of the Left Auditory Cortex in Acute State Schizophrenia” [EBioMedicine 12 (2016) 143-149]
by: Hironori Kuga, et al.
Published: (2017-02-01)

The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
by: Li Hua-Bin, et al.
Published: (2009-09-01)

Corrigendum to ‘CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours’ [EBioMedicine 49 (2019) 82–95]
by: Francisco M. Vega, et al.
Published: (2020-03-01)

Corrigendum to ‘‘Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type’’ [EBioMedicine 51 (2020) 102526]
by: Qi Cai, et al.
Published: (2020-05-01)

Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015) 1133–1144]
by: H. Ross-Adams, et al.
Published: (2017-03-01)

Corrigendum to ‘MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway’ [EBioMedicine 46 (2019) 66–78]
by: Wei-Wei Wang, et al.
Published: (2020-05-01)

Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275>
by: Yu Gan, et al.
Published: (2020-04-01)

Corrigendum to: “Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study” [EBioMedicine 3 (216) 135–140]
by: Magnus Gisslén, et al.
Published: (2016-05-01)

Corrigendum to “Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer” (EBioMedicine Aug 2016; 10: 124–36)
by: Tzu-Tang Wei
Published: (2017-12-01)

Corrigendum to ‘Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer’ [EBioMedicine 31 (2018) 276–286]
by: Tao Zhang, et al.
Published: (2020-02-01)

Corrigendum to “One of the Immune Activation Profiles Observed in HIV-1-Infected Adults with Suppressed Viremia is Linked to Metabolic Syndrome: The ACTIVIH Study” [EBioMedicine 8 (2016) 265–276]
by: Christina Psomas, et al.
Published: (2016-08-01)

Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456
by: LaTonya J. Hickson, et al.
Published: (2020-02-01)

Corrigendum to “Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge” [EBioMedicine 2 (2015) 1438-1446]
by: Jiaming Lan, et al.
Published: (2021-10-01)

LPS Enhances the Chemosensitivity of Oxaliplatin in HT29 Cells via GSDMD-Mediated Pyroptosis
by: Wu LS, et al.
Published: (2020-10-01)

Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]
by: Pinar Kanlikilicer, et al.
Published: (2020-02-01)

Corrigendum to “Assessment of Human Tribbles Homolog 3 Genetic Variation (rs2295490) Effects on Type 2 Diabetes Patients with Glucose Control and Blood Pressure Lowering Treatment” [EBioMedicine 13 (2016) 181–189]
by: Fazhong He, et al.
Published: (2017-03-01)

Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]
by: Chung-Feng Huang, et al.
Published: (2017-03-01)

Corrigendum to “A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer” [EBioMedicine 44 (2019) 311– 321]
by: Feifei Zhang, et al.
Published: (2021-07-01)

PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.
by: Danna Yeerken, et al.
Published: (2020-01-01)

Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305]
by: Simon Fishel, et al.
Published: (2016-11-01)